In today's @TheLancet there are 3 papers on cardiometabolic disease: biology, epidemiology, prevention/treatment.
The sobering and all to common story from womb to tomb conveyed in this graphic
https://t.co/rVs2Yz97NC
https://t.co/OpuJTia0bC
https://t.co/i714onXoCG
Thrilled to share that our paper is out in @NEJMEvidence.
Using a Weighted Composite Endpoint (WCE), we analyzed AFib trial data and assessed DOAC effects through a patient preference-informed metric.
Grateful to all mentors and collaborators!
https://t.co/RIWLFV4TSq